Early Cancer Detection Tests and Other Useful Tests |
| Written by JMB | |
|
The sooner you find cancer, the sooner you can begin to fight it. Here is a list of early-detection tests, including some so new, even your doctor may not know about them! Cancer Detection Tests
There are different types of laboratory tests, which can be conducted to detect cancer. There are standard tests and less toxic tests and some of these are not referred by physicians. It is always safe to get multiple tests done. Some of the laboratory tests for detecting cancer are:
AMAS: This is called the Anti-malignin antibody screen test and it can pick up different symptoms of cancer in advance and much before any of the conventional tests can. It is not recommended in advanced stages of cancer as there are chances that the anti-malignin antibody has been wiped out and hence the test will be ineffective. See for more information: http://www.oncolabinc.com/
Biological Terrain Assessment (BTA): This computerized device can measure the blood, urine, and saliva for pH balance, electrons present, and various minerals present in the fluid. This assessment can find out if your cellular environment is more acidic in nature or not.
Cancer Marker Tests: Cancer markers are produced when cancer grows. They can be detected much before they can become big enough to be detected by the traditional or conventional tests. It is an early detection system that will increases the chances of early medical intervention.
Darkfield Microscopy: With the help of this test, doctors can view blood cells and reach a conclusion regarding their health. On the basis of the results, other lab tests can be performed for providing a comprehensive picture of the patient’s medical condition.
DR-70: The DR-70 is a blood test that can identify 13 types of cancers simultaneously. This blood test is extremely specific in nature and can identify cancer in its early stages itself. Cancers detected through the DR-70 test include colon, lung, breast, liver, stomach, rectum, cervix, ovary, esophagus, pancreas, thyroid, malignant lymphoma and trophoblast.
Electro Dermal Screening (EDS): EDS is a computerized screening test that takes acupuncture reading into consideration to indicate the health of various organs and that of the body as a whole.
Some of the other tests include Endoscopic ultrasound, Lymphocyte Size Analysis, Maverick Monitoring Test (MMT), Positron Emission Tomography or PET scan, Thermography, T/Tn Antigen Test, BTA TRAK test, Acueity ductoscopy and Ductal lavage.
http://www.lef.org/bloodtest/bloodtest2.html or 800-208-3444 http://www.iact-org.org/breast_thermography.html http://www.cancure.org/breast_thermography.htm http://www.urologychannel.com/bladdercancer/diagnosis.shtml
AMAS – Anti-Malignin Antibody in Serum
It’s been found that the anti-malignin antibody in serum or AMAS test by Oncolab, Boston, MA is 97% sensitive and 95% specific for malignancies. The AMAS is considered to be one of the most reliable and scientifically proven laboratory blood test for detecting over 99% of all types of cancers. Largely most doctors are unaware of the AMAS test; therefore patients haven’t been able to take advantage of this test at an early stage.
About the AMAS Test:
An extremely sensitive test, under the AMAS the antibody blood levels scale up during almost all types of cancers, irrespective of the location of infection in the body. A diagnostic test, the AMAS is used to test for circulating levels of a particular antibody and acts as a unique tool for monitoring patients suffering from cancer while in remission. When these antibodies attach specifically to a 10,000 molecular weight protein that is found in a wide range of cancers, the test can be claimed to be successful.
Furthermore, because the AMAS actually monitors one aspect of the human body’s immune response to cancer and does not monitor cancer cells in the blood stream or cancer antigens, this test gives accurate results especially for early detection or recurrence of cancer, when the signs of this disease are not even evident clinically.
This test is very useful in observing the treatments of malignancies. The antibody levels usually return to normal within the first 2-3 months of successful treatment. Moreover, the other variants in the blood that specify presence of malignancies generally do not rise during the early stage or recurrence of the disease. Therefore, the AMAS test is a superb way to screen and detect cancer or its recurrence and thereby track the progress and success of the treatment.
While the anti-malignant antibody in serum test is not useful for detecting advanced cancer, its level of accuracy and high sensitivity especially during early cancer occurrence or recurrence of the disease, provide a useful tool for doctors around the world for deciding the treatment.
The AMAS test, a diagnostic test which tests for circulating levels of a specific antibody, provides a unique tool for monitoring cancer patients in remission. The antibodies bind specifically to a 10,000 molecular weight protein found in a wide range of cancers. Because it monitors an aspect of the body’s immune response to cancer, rather than cancer antigens or cancer cells in the bloodstream, the AMAS test is especially accurate early in the recurrence or first occurrence of cancer, when clinical signs of the disease may not be evident or may just be emerging.
Patients in remission after successful cancer therapy, or a healthy normal population, generally have normal circulating levels of the antibody assayed in the test. AMAS’s low false positive rate, shown to be 5% in double-blind clinical studies, means that elevated results on the test are highly suspicious for a recurrence or unrelated new occurrence of cancer, and warrant further clinical investigation.
While the AMAS test is not generally useful in advanced cancer, its high sensitivity and specificity early in the disease allow it to be used to improve early detection of first occurrence and recurrence of the disease.
The emergence of new imaging techniques such as MRI and CT scans provides a powerful complement to the AMAS test’s ability to flag early cancer occurrence and recurrence. With these tools, which are now becoming affordable and widely used, it is often possible to find small malignancies, leading to early and effective clinical treatment. Survival rates for cancers found early are generally much better than for those found later in the disease, and death rates, treatment costs, and productivity losses can be minimized
AMAS and survival dataBoth monitoring data and a retrospective survival study of 511 cancer patients) have shown that the AMAS test may be useful in indicating disease progression and prognosis. Thus in known cancer patients, when the immune response is good as evidenced by high antibody levels, the prognosis is good; and when the antibody level falls, the prognosis is poor. Anti-Malignin Antibody is the first general cancer antibody found to relate to patient survival. The test therefore may be useful as an adjunct to standard (sometimes less accurate) staging information such as the spread of malignancy beyond the capsule of the primary organ and the presence of metastases in lymph nodes, or general symptoms such as anemia, weight loss and fatigue. Limitations and Warnings
http://cebp.aacrjournals.org/cgi/content/full/14/10/2310
Darkfield Blood Analysis
For over a century, scientists have been analyzing samples of human blood. Way back in 1856, an unsuccessful synthesis by William Perkin brought together blood analysis and new chemical information. Perkin’s inability to synthesize quinine yielded mauve, demonstrated the ability of coal tar to stain human tissue.
Darkfield blood analysis provides researchers with a way to examine live blood cells. An opaque disc is placed under the microscope lens. That disc forces all light directed at the blood sample to hit that sample from the sides. The blood cells are viewed against a dark background. One other modern-day invention has added to the significance of the darkfield analysis. That invention is the video camera. No longer does the scientist need to depend on still pictures to show what he or she has seen in a microscope. Now the scientist can capture with a video camera the movement of live cells. Thanks to darkfield analysis, the researchers have live blood cells that can be caught on the video camera. Darkfield analysis aids the discovery of things once hidden from the eyes of analytical scientists. With darkfield analysis, a scientist does not peer into a light. The scientist views only reflected light. That allows different aspects of the blood and blood cells to stand-out.
A number of different medical problems can now be diagnosed by the analysis of a live blood sample. Metal toxicity is one such problem. In the past when a doctor suspected metal toxicity, he or she could request a blood test, but that test would take time. The laboratory would need to carry-out a series of chemical reactions, to see if any reactions yielded evidence that a toxin had entered the patient’s blood.
Thanks to darkfield blood analysis, a doctor who suspects metal toxicity in a patient can have his or her suspicions confirmed quickly and easily. A drop of blood is taken from the patient’s finger. The blood is analyzed under a darkfield. If that analysis reveals the presence of crystals in the blood plasma, then the doctor has proof that the patient suffers from metal toxicity.A darkfield analysis provides useful information that might suggest the need for diet changes on the part of the patient. The darkfield analysis can shed light on a patient’s vitamin or mineral deficiencies. Sometimes those deficiencies can diminish the ability of the blood to provide the cells with oxygen.In a sample of blood from a healthy patient the blood cells do not aggregate in any fashion. Improper diet can, however, cause the red blood cells to form “stacks.” That is a condition called “rouleau.” Its exact cause has yet to be determined, although it appears linked to either metabolism or pH balance, factors that respond to dietary changes.
Conventional analysis of the blood offered more useful information if the patient had been fasting. The patient was asked to arrive at the lab early in the morning, before eating breakfast. If that was not possible, then the patient was told to go to the lab no sooner than two hours after a meal.With darkfield analysis, the laboratory does not have to worry about the possible effect of recently eaten food. During the darkfield analysis, the trained technician can see food particles in the blood plasma. The technician can note whether or not those food particles interfere with the functions of the red and white blood cells.Still, a patient who will provide blood for a darkfield analysis should know a few basics about cholesterol testing. The patient should sit down before having his or her finger pricked. The composition of the blood taken from the finger depends on the creation of blood pools within the body. The pools in a standing person differ from those in a sitting individual. Some patients like to appear very “brave” when they have their finger pricked, and when they let the technician get the blood sample. Some patients do not object when the technician squeezes their finger. Those patients should be more assertive. When the technician squeezes the patient’s finger, that forces fluid from the cells in that finger. The added fluid can dilute the blood sample.
Patients must realize that the composition of blood changes constantly. The results of a darkfield analysis taken today could not be replicated, if that analysis were taken tomorrow. Unless a doctor could somehow watch the insides of a blood vessel for a number of days, there would be only one way around the changing composition of the patient’s blood. That involves repeated blood drawings.
.
Interesting “demise” of RBCs less than 24 hours after root canal.
For more information: http://darkfieldstudies.com
|
For decades and decades, researchers would stain a sample of blood before examining that blood sample under the microscope. The stain killed the blood cells. The researcher remained clueless about the nature of live blood. Researchers also needed a way to view the almost invisible structures inside the cell, structures such as the chromosomes and the mitochondria. By the last third of the 20th Century, researchers had found ways to better view the small structures in the cell. They started using electron microscopes. Yet cells viewed under an electron microscope were not living cells. Researchers still lacked the ability to view the workings of a living cell. 
Darkfield analysis can provide evidence of “stacking.” Darkfield analysis of a patient’s blood can also reveal information about the patient’s atherosclerotic predisposition. What does that mean? It means that a darkfield analysis can help to monitor the amount of cholesterol in the patient’s bloodstream. A build-up of cholesterol in the blood stream can lead to the formation of cholesterol “plagues” on the artery walls. That leads to arteriosclerosis, also known as “hardening of the arteries.” The darkfield analysis of blood gives the physician yet another tool to add to those already in his or her “cholesterol testing kit.”Following a darkfield analysis, a physician might be provided with some video footage. If the physician could show to his or her patient how unhealthy food had allowed fat to form in the blood plasma, then that patient might try harder to avoid such fatty food. The darkfield analysis can help the physician to counsel the patient about his or her diet. 
Somewhat typical example of red and white blood cells. It is a fasting sample so the plasma is quite clean, but some RBCs have circles inside, usually called “target cells” by darkfield microscopists, but they have other names as well. This is normally interpreted as indication that the cells are nutritionally deficient. RBCs are somewhat flat, biconcave discs, so that after they have delivered nutrients to tissue, they are a little thinner and the light passes more easily through the middle instead of only illuminating the edges.
Similar Posts:
|
|
|
|
|
 |
